Integrative Onkologie
Natürliche komplementäre Therapien für Krebspflege
Natürliche alternative Therapien mit analgetischen, entzündungshemmenden und immunstimulierenden Eigenschaften, die Krebssymptome lindern und das Überleben verlängern.
Unser Vorgehen
Stage 3–4 cancer support
Immunostimulant therapies
Pain management
Quality of life improvement
Nutritional oncology support
Psychological support
Beginnen Sie Ihre Reise zur Genesung
Senden Sie Ihre Krankenakte und Befunde, und unsere Spezialisten werden Ihren Fall prüfen und einen personalisierten Behandlungsplan empfehlen, der auf Ihre Bedürfnisse zugeschnitten ist.
Beratung AnfragenWhatsAppUnsere Medizinischen Programme auf einen Blick
Vergleichen Sie Fokus, Schlüsseltherapien, Aufenthalt und ideale Kandidaten unserer Hauptprogramme.
| Programm | Hauptfokus | Schlüsseltherapie / Innovation | Typischer Aufenthalt | Behandlungsrahmen | Ideal Für |
|---|---|---|---|---|---|
| Integrative Onkologie | Unterstützung bei fortgeschrittenem Krebs | CIMAvax-EGF®, VAXIRA®, HEBERSaVax®, VIDATOX® | 2–4 Wochen | Stationär & ambulant | Krebspatienten Stadium 3–4 |
| Physikalische Rehabilitation | Neurologische, orthopädische & kardiopulmonale Genesung | NeuralCIM®, fortgeschrittene Physiotherapie | 3–6 Wochen | Stationär intensiv | Schlaganfall, Schädel-Hirn-Trauma, postoperativ |
| Behandlung des Diabetischen Fußes | Diabetisches Fußulkus & Gliedmaßenrettung | Heberprot-P®, fortschrittliche Wundversorgung | 2–6 Wochen | Stationär & ambulant | Diabetes-Ulzera, Gangrän-Risiko |
| Früherkennung Gefäßerkrankungen | Frühe Gefäßrisikoerkennung | Nicht-invasives Gefäß-Screening | 2–5 Tage | Ambulantes Screening | Präventives Herz-Kreislauf-Screening |
| Hämodialyse im Urlaub | Fortgesetzte Nierenpflege auf Reisen | Moderne Hämodialyse + Nephrologie-Team | Pro Sitzung / fortlaufend | Ambulante Dialyse-Einheit | Dialysepatienten auf Kuba-Reise |
| Ayurvedische Medizin | Ganzheitliche Entgiftung & chronische Krankheiten | Panchakarma, Pflanzenheilkunde, Yoga | 2–3 Wochen | Wohlfühlresidenz | Stress, chronische Erkrankungen, Entgiftung |
| Lebensqualität | Präventive Gesundheits- & Vorsorgeuntersuchung | Vorsorge, Lebensstilplanung | 3–7 Tage | Ambulante Untersuchung | Gesundheitsbewusste Erwachsene, Executive-Check-up |
| Suchtbehandlung | Sucht- & Verhaltensabhängigkeit | Entgiftung, psychiatrische & Verhaltenstherapie | 4–8 Wochen | Stationär in der Natur | Substanz- & Verhaltensabhängigkeiten |
Die Aufenthaltsdauer sind Schätzungen; Ihr persönlicher Plan wird nach ärztlicher Beratung bestätigt.
Medical Evaluation Process
A clear, structured process guides you from first contact through to the completion of treatment.
1. Initial Consultation Request
Submit your medical records and treatment inquiry through our secure online consultation form. Our international patient coordinators review your case within 24 hours.
2. Specialist Medical Review
A board-certified specialist in the relevant discipline reviews your diagnosis, imaging, and laboratory results to determine suitability for the program.
3. Personalized Treatment Plan
Based on the review, our medical team develops an individualized treatment protocol with detailed timelines, therapies, and estimated costs.
4. Travel & Accommodation Coordination
Our concierge team handles visa support letters, flight coordination, airport transfers, and accommodation in partner hotels near the health center.
5. On-Arrival Assessment & Treatment
Upon arrival, a final in-person assessment confirms the plan. Treatment begins under continuous multidisciplinary medical supervision.
Treatment Duration
Treatment duration varies by program and individual patient needs. Most international medical programs at La Pradera range from 2 to 6 weeks, allowing sufficient time for comprehensive assessment, therapeutic intervention, and recovery monitoring. Your personalized treatment plan will include a precise estimated timeline after the specialist medical review.
Patient Eligibility
- Adults (18+) with a confirmed medical diagnosis appropriate for the selected program
- Completed medical records including recent imaging and laboratory results
- Medical clearance for international travel
- No uncontrolled acute conditions that would prevent safe treatment
- Willingness to comply with the prescribed treatment protocol and follow-up schedule
- Valid passport and ability to obtain a Cuban medical visa (support letter provided)
Why Choose Cuba for Medical Treatment
Accredited by Cuba's Ministry of Public Health (MINSAP)
Decades of experience treating international patients from over 40 countries
Pioneering Cuban biotechnology: CIMAvax-EGF®, Heberprot-P®, NeuralCIM®
Transparent, all-inclusive pricing with no hidden fees
Frequently Asked Questions
How do I begin my medical treatment in Cuba?
Begin by submitting a consultation request through our online form. Our international patient coordinators will review your medical records and connect you with the appropriate specialist within 24 hours to develop a personalized treatment plan.
Do I need a visa to travel to Cuba for medical treatment?
Yes. International patients require a Cuban medical visa. La Pradera provides an official invitation letter once your treatment plan is confirmed, which you submit with your visa application at the Cuban consulate in your country.
Is the treatment at La Pradera covered by international health insurance?
Coverage depends on your insurance provider and policy. We recommend contacting your insurer before travel. La Pradera provides detailed medical reports and invoices that you can submit for reimbursement. Direct payment options are also available.
What language support is available for international patients?
Our international patient services team provides interpretation in English, Spanish, Arabic, French, Russian, Turkish, and other languages. Medical consultations are conducted with professional interpreters to ensure clear communication throughout your treatment.
Can a family member or companion accompany me during treatment?
Yes. We encourage patients to travel with a companion. Accommodation can be arranged for family members in nearby partner hotels, and our concierge team assists with their travel and stay arrangements.
Explore Other Programs
Physikalische Rehabilitation
Umfassende, intensive und personalisierte physikalische Rehabilitation für Kinder und Erwachsene mit
Learn moreLebensqualität
Krankheitsprävention und Früherkennung durch personalisierte Gesundheitsuntersuchungen. Wir fördern
Learn moreAyurvedische Medizin
Die „Wissenschaft des Lebens“ — uraltes Wissen mit über 5.000 Jahren Anwendung. Therapien stellen da
Learn moreHämodialyse im Urlaub
Genießen Sie Ihren Urlaub auf Kuba, ohne die Hämodialyse zu unterbrechen. Vollständige medizinische
Learn moreKrebsarten, die wir behandeln
Detaillierte Informationen über spezifische Erkrankungen, die in unserem Programm behandelt werden.
Überblick
Lung cancer is one of the most common and serious types of cancer worldwide. La Pradera offers treatment with CIMAvax-EGF®, the world's first therapeutic vaccine for non-small-cell lung cancer (NSCLC), developed by Cuba's Center of Molecular Immunology (CIM). Unlike preventive vaccines, CIMAvax-EGF® stimulates the patient's immune system to produce antibodies against epidermal growth factor (EGF), depriving cancer cells of the protein they need to multiply and grow.
Wer profitieren kann
Adults diagnosed with stage IIIB or IV non-small-cell lung cancer (NSCLC) who have completed or are completing first-line oncology treatment (chemotherapy or radiotherapy). The vaccine is used as maintenance therapy to help control tumor growth and extend survival.
Verfahren
After eligibility assessment, patients receive a series of intramuscular injections of CIMAvax-EGF® over a structured treatment protocol. The regimen begins with an induction phase of 5 doses in the first month, followed by monthly maintenance injections. Treatment is administered under continuous medical supervision with regular imaging and blood work to monitor response.
Vorteile
- Stimulates the body's own immune system to target cancer cells
- Low toxicity profile compared to conventional chemotherapy
- Outpatient administration — no hospitalization required for each dose
- Improves quality of life during maintenance phase
- Developed by Cuba's Center of Molecular Immunology with over a decade of clinical use
Kontraindikationen
Not suitable for patients with small-cell lung cancer (SCLC), pregnant or breastfeeding women, patients with active autoimmune diseases, or those with severe uncontrolled medical conditions. A full medical evaluation determines eligibility.
Erwartete Ergebnisse
Clinical studies indicate that CIMAvax-EGF® can slow disease progression and improve survival in eligible patients, particularly those with high EGF levels. Results vary by individual; the medical team provides a personalized prognosis after reviewing each case.
Kubanische Medizinische Innovationen
Medizinische Programme · La Pradera
CIMAvax-EGF®
Therapeutischer Impfstoff gegen Lungenkrebs.
VAXIRA®
Therapeutischer Impfstoff von kubanischen und argentinischen Wissenschaftlern.
HEBERSaVax®
Neuer therapeutischer Krebsimpfstoff vom CIGB.
VIDATOX® 30CH
Homöopathisches Medikament aus dem Gift des blauen Skorpions.
Wissenschaftliche Referenzen
- 1Rodríguez PC, et al. CIMAvax-EGF immunotherapy in advanced non-small cell lung cancer: Survival and immune response. Clinical Cancer Research.Quelle: Center of Molecular Immunology (CIM)Referenz ansehen
- 2Rodríguez PC, et al. CIMAvax-EGF: A novel therapeutic vaccine for non-small-cell lung cancer. Journal of Clinical Oncology.Quelle: Center of Molecular Immunology (CIM), Havana, CubaReferenz ansehen
- 3Berlanga Acosta J, et al. Heberprot-P: Recombinant human epidermal growth factor for diabetic foot ulcers. International Wound Journal.Quelle: Center for Genetic Engineering and Biotechnology (CIGB), Havana, CubaReferenz ansehen
- 4Cuban Ministry of Public Health (MINSAP). National Health Statistics Annual Report.Quelle: Ministry of Public Health of CubaReferenz ansehen
Wir verwenden Cookies, um Ihre Erfahrung zu verbessern und den Datenverkehr zu analysieren. Mit der Fortsetzung stimmen Sie unserer Verwendung von Cookies zu. Datenschutzerklärung